Clinical Trials Browser

Phase 1/2 × Extensive Stage Small Cell Lung Cancer × 30 days × Clear all

NCT05142696 2026-05-29

A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

Phase 1/2 Active not recruiting

Extensive Stage Small Cell Lung Cancer